Early trial tests common Drug's effect on deadly brain cancer
NCT ID NCT07387666
Summary
This early research study aims to understand how Acetadote affects metabolism in glioblastoma brain tumors. Researchers will give Acetadote to 10 newly diagnosed patients before surgery, then analyze tumor tissue and MRI scans to see how the drug changes tumor chemistry. The goal is to gather basic information about whether affecting tumor metabolism could potentially slow tumor growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Contact
Conditions
Explore the condition pages connected to this study.